Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1549 entries
Sorted by: Best Match Show Resources per page
STEM Studies: Enhancing 21 st Century Skills through Robotics

STEM training programs

Simon K, Wing C.
GSID: ms7A1C71C1gJ
C Wing, K Simon… - Annual review of public …, 2018 - annualreviews.org

… as the engineering component of a STEM grant. It was originally … Implementation ideas, teacher training, student activities, … program on academic achievement and interest in STEM …

Efficient recognition of adverse drug reactions.

Acta medica Hungarica

Simon K.
PMID: 3671020
Acta Med Hung. 1987;44(1):65-9.

The author discusses the possibility of detection of adverse drug effects. Two methods of data collection are compared: the "side effect oriented" and the "change oriented" method. Well-known and new adverse effect may be detected with greater probability by...

Cite
Simon K. Efficient recognition of adverse drug reactions. Acta Med Hung. 1987;44(1):65-9
Simon, K. (1987). Efficient recognition of adverse drug reactions. Acta medica Hungarica, 44(1), 65-9.
Simon, K. "Efficient recognition of adverse drug reactions." Acta medica Hungarica vol. 44,1 (1987): 65-9.
Simon K. Efficient recognition of adverse drug reactions. Acta Med Hung. 1987;44(1):65-9. PMID: 3671020.
Copy Download .nbib Format: NLM
Are pediatric emergency medicine training programs meeting their goals and objectives? A self-assessment of individuals completing fellowship training in 1993.

Pediatric emergency care

Simon HK, Steele DW, Lewander WJ, Linakis JG.
PMID: 7937297
Pediatr Emerg Care. 1994 Aug;10(4):208-12. doi: 10.1097/00006565-199408000-00006.

The purpose of this study was to evaluate the overall training experience of those individuals completing fellowships in pediatric emergency medicine. Specific attention was given to the technical skills portion of training as set forth by the American Academy...

Cite
Simon HK, Steele DW, Lewander WJ, et al. Are pediatric emergency medicine training programs meeting their goals and objectives? A self-assessment of individuals completing fellowship training in 1993. Pediatr Emerg Care. 1994;10(4):208-12doi: 10.1097/00006565-199408000-00006.
Simon, H. K., Steele, D. W., Lewander, W. J., & Linakis, J. G. (1994). Are pediatric emergency medicine training programs meeting their goals and objectives? A self-assessment of individuals completing fellowship training in 1993. Pediatric emergency care, 10(4), 208-12. https://doi.org/10.1097/00006565-199408000-00006
Simon, H K, et al. "Are pediatric emergency medicine training programs meeting their goals and objectives? A self-assessment of individuals completing fellowship training in 1993." Pediatric emergency care vol. 10,4 (1994): 208-12. doi: https://doi.org/10.1097/00006565-199408000-00006
Simon HK, Steele DW, Lewander WJ, Linakis JG. Are pediatric emergency medicine training programs meeting their goals and objectives? A self-assessment of individuals completing fellowship training in 1993. Pediatr Emerg Care. 1994 Aug;10(4):208-12. doi: 10.1097/00006565-199408000-00006. PMID: 7937297.
Copy Download .nbib Format: NLM
[ECG characteristics of acute myocardial ischemia].

Orvosi hetilap

Szabó P, Szelier A, Szépvölgyi A, Turi T, Simon K.
PMID: 2726249
Orv Hetil. 1989 May 07;130(19):999-1000.

UNLABELLED: The authors discussed the efficacy of ECG in distinction of reversible and irreversible myocardial damage. On the basis of continuous ECG monitoring of a patient, suffering from acute ischemic syndrome, it was established, that neither the appearance of...

Cite
Szabó P, Szelier A, Szépvölgyi A, et al. A heveny myocardialis ischaemia EKG képe. [ECG characteristics of acute myocardial ischemia]. Orv Hetil. 1989;130(19):999-1000
Szabó, P., Szelier, A., Szépvölgyi, A., Turi, T., & Simon, K. (1989). A heveny myocardialis ischaemia EKG képe. [ECG characteristics of acute myocardial ischemia]. Orvosi hetilap, 130(19), 999-1000.
Szabó, P, et al. "A heveny myocardialis ischaemia EKG képe." [ECG characteristics of acute myocardial ischemia]. Orvosi hetilap vol. 130,19 (1989): 999-1000.
Szabó P, Szelier A, Szépvölgyi A, Turi T, Simon K. A heveny myocardialis ischaemia EKG képe. [ECG characteristics of acute myocardial ischemia]. Orv Hetil. 1989 May 07;130(19):999-1000. Hungarian. PMID: 2726249.
Copy Download .nbib Format: NLM
Radiation dose estimation of patients undergoing lumbar spine radiography.

Journal of medical physics

Gyekye PK, Simon A, Geoffrey ER, Johnson Y, Stephen I, Engmann CK, Samuel WG.
PMID: 24672153
J Med Phys. 2013 Oct;38(4):185-8. doi: 10.4103/0971-6203.121196.

Radiation dose to organs of 100 adult patients undergoing lumbar spine (LS) radiography at a University Hospital have been assessed. Free in air kerma measurement using an ionization chamber was used for the patient dosimetry. Organ and effective dose...

Cite
Gyekye PK, Simon A, Geoffrey ER, et al. Radiation dose estimation of patients undergoing lumbar spine radiography. J Med Phys. 2013;38(4):185-8doi: 10.4103/0971-6203.121196.
Gyekye, P. K., Simon, A., Geoffrey, E. R., Johnson, Y., Stephen, I., Engmann, C. K., & Samuel, W. G. (2013). Radiation dose estimation of patients undergoing lumbar spine radiography. Journal of medical physics, 38(4), 185-8. https://doi.org/10.4103/0971-6203.121196
Gyekye, Prince Kwabena, et al. "Radiation dose estimation of patients undergoing lumbar spine radiography." Journal of medical physics vol. 38,4 (2013): 185-8. doi: https://doi.org/10.4103/0971-6203.121196
Gyekye PK, Simon A, Geoffrey ER, Johnson Y, Stephen I, Engmann CK, Samuel WG. Radiation dose estimation of patients undergoing lumbar spine radiography. J Med Phys. 2013 Oct;38(4):185-8. doi: 10.4103/0971-6203.121196. PMID: 24672153; PMCID: PMC3958998.
Copy Download .nbib Format: NLM
Oxidation by hydrogen in the chemistry and physics of the rare-earth metals.

Angewandte Chemie (International ed. in English)

Simon A.
PMID: 22431365
Angew Chem Int Ed Engl. 2012 Apr 27;51(18):4280-6. doi: 10.1002/anie.201108558. Epub 2012 Mar 16.

Rare-earth metals (RE) easily react with hydrogen. For decades the bonding of hydrogen has been discussed controversially in terms of either the "proton model" or the "anion model". Detailed investigations of metal-rich compounds of the rare-earth metals provide clear...

Cite
Simon A. Oxidation by hydrogen in the chemistry and physics of the rare-earth metals. Angew Chem Int Ed Engl. 2012;51(18):4280-6doi: 10.1002/anie.201108558.
Simon, A. (2012). Oxidation by hydrogen in the chemistry and physics of the rare-earth metals. Angewandte Chemie (International ed. in English), 51(18), 4280-6. https://doi.org/10.1002/anie.201108558
Simon, Arndt. "Oxidation by hydrogen in the chemistry and physics of the rare-earth metals." Angewandte Chemie (International ed. in English) vol. 51,18 (2012): 4280-6. doi: https://doi.org/10.1002/anie.201108558
Simon A. Oxidation by hydrogen in the chemistry and physics of the rare-earth metals. Angew Chem Int Ed Engl. 2012 Apr 27;51(18):4280-6. doi: 10.1002/anie.201108558. Epub 2012 Mar 16. PMID: 22431365.
Copy Download .nbib Format: NLM
Germline whole exome sequencing and large-scale replication identifies .

Oncotarget

Dicks E, Song H, Ramus SJ, Oudenhove EV, Tyrer JP, Intermaggio MP, Kar S, Harrington P, Bowtell DD, Group AS, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, Piskorz A, Goranova T, Kent E, Siddiqui N, Paul J, Crawford R, Poblete S, Lele S, Sucheston-Campbell L, Moysich KB, Sieh W, McGuire V, Lester J, Odunsi K, Whittemore AS, Bogdanova N, Dürst M, Hillemanns P, Karlan BY, Gentry-Maharaj A, Menon U, Tischkowitz M, Levine D, Brenton JD, Dörk T, Goode EL, Gayther SA, Pharoah DPP.
PMID: 28881617
Oncotarget. 2017 Mar 03;8(31):50930-50940. doi: 10.18632/oncotarget.15871. eCollection 2017 Aug 01.

We analyzed whole exome sequencing data in germline DNA from 412 high grade serous ovarian cancer (HGSOC) cases from The Cancer Genome Atlas Project and identified 5,517 genes harboring a predicted deleterious germline coding mutation in at least one...

Cite
Dicks E, Song H, Ramus SJ, et al. Germline whole exome sequencing and large-scale replication identifies . Oncotarget. 2017;8(31):50930-50940doi: 10.18632/oncotarget.15871.
Dicks, E., Song, H., Ramus, S. J., Oudenhove, E. V., Tyrer, J. P., Intermaggio, M. P., Kar, S., Harrington, P., Bowtell, D. D., Group, A. S., Cicek, M. S., Cunningham, J. M., Fridley, B. L., Alsop, J., Jimenez-Linan, M., Piskorz, A., Goranova, T., Kent, E., Siddiqui, N., Paul, J., Crawford, R., Poblete, S., Lele, S., Sucheston-Campbell, L., Moysich, K. B., Sieh, W., McGuire, V., Lester, J., Odunsi, K., Whittemore, A. S., Bogdanova, N., Dürst, M., Hillemanns, P., Karlan, B. Y., Gentry-Maharaj, A., Menon, U., Tischkowitz, M., Levine, D., Brenton, J. D., Dörk, T., Goode, E. L., Gayther, S. A., & Pharoah, D. P. P. (2017). Germline whole exome sequencing and large-scale replication identifies . Oncotarget, 8(31), 50930-50940. https://doi.org/10.18632/oncotarget.15871
Dicks, Ed, et al. "Germline whole exome sequencing and large-scale replication identifies ." Oncotarget vol. 8,31 (2017): 50930-50940. doi: https://doi.org/10.18632/oncotarget.15871
Dicks E, Song H, Ramus SJ, Oudenhove EV, Tyrer JP, Intermaggio MP, Kar S, Harrington P, Bowtell DD, Group AS, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, Piskorz A, Goranova T, Kent E, Siddiqui N, Paul J, Crawford R, Poblete S, Lele S, Sucheston-Campbell L, Moysich KB, Sieh W, McGuire V, Lester J, Odunsi K, Whittemore AS, Bogdanova N, Dürst M, Hillemanns P, Karlan BY, Gentry-Maharaj A, Menon U, Tischkowitz M, Levine D, Brenton JD, Dörk T, Goode EL, Gayther SA, Pharoah DPP. Germline whole exome sequencing and large-scale replication identifies . Oncotarget. 2017 Mar 03;8(31):50930-50940. doi: 10.18632/oncotarget.15871. eCollection 2017 Aug 01. PMID: 28881617; PMCID: PMC5584218.
Copy Download .nbib Format: NLM
The Opposite Expected Effect of p38 Inhibitors on Fat Graft Survival.

Plastic and reconstructive surgery. Global open

Filson SA, Keren A, Goldstein N, Ullmann Y.
PMID: 27536485
Plast Reconstr Surg Glob Open. 2016 Jul 15;4(7):e806. doi: 10.1097/GOX.0000000000000821. eCollection 2016 Jul.

BACKGROUND: Fat grafting is an increasingly popular method of augmentation/reconstruction of soft tissue defects. However, the clinical unpredictability and high resorption rates of the grafts remain problematic. Cellular stress from the harvest and the ensuing ischemic episode may be...

Cite
Filson SA, Keren A, Goldstein N, et al. The Opposite Expected Effect of p38 Inhibitors on Fat Graft Survival. Plast Reconstr Surg Glob Open. 2016;4(7):e806doi: 10.1097/GOX.0000000000000821.
Filson, S. A., Keren, A., Goldstein, N., & Ullmann, Y. (2016). The Opposite Expected Effect of p38 Inhibitors on Fat Graft Survival. Plastic and reconstructive surgery. Global open, 4(7), e806. https://doi.org/10.1097/GOX.0000000000000821
Filson, Simon A, et al. "The Opposite Expected Effect of p38 Inhibitors on Fat Graft Survival." Plastic and reconstructive surgery. Global open vol. 4,7 (2016): e806. doi: https://doi.org/10.1097/GOX.0000000000000821
Filson SA, Keren A, Goldstein N, Ullmann Y. The Opposite Expected Effect of p38 Inhibitors on Fat Graft Survival. Plast Reconstr Surg Glob Open. 2016 Jul 15;4(7):e806. doi: 10.1097/GOX.0000000000000821. eCollection 2016 Jul. PMID: 27536485; PMCID: PMC4977134.
Copy Download .nbib Format: NLM
Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent .

Frontiers in cardiovascular medicine

Flannigan KL, Rajbar T, Moffat A, McKenzie LS, Dicke F, Rioux K, Workentine ML, Louie TJ, Hirota SA, Greenway SC.
PMID: 28421185
Front Cardiovasc Med. 2017 Apr 04;4:17. doi: 10.3389/fcvm.2017.00017. eCollection 2017.

The microbiome is increasingly recognized as an important influence on human health and many of the comorbidities that affect patients after solid organ transplantation (SOT) have been shown to involve changes in gut bacterial populations. Thus, microbiome changes in...

Cite
Flannigan KL, Rajbar T, Moffat A, et al. Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent . Front Cardiovasc Med. 2017;4:17doi: 10.3389/fcvm.2017.00017.
Flannigan, K. L., Rajbar, T., Moffat, A., McKenzie, L. S., Dicke, F., Rioux, K., Workentine, M. L., Louie, T. J., Hirota, S. A., & Greenway, S. C. (2017). Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent . Frontiers in cardiovascular medicine, 417. https://doi.org/10.3389/fcvm.2017.00017
Flannigan, Kyle L, et al. "Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent ." Frontiers in cardiovascular medicine vol. 4 (2017): 17. doi: https://doi.org/10.3389/fcvm.2017.00017
Flannigan KL, Rajbar T, Moffat A, McKenzie LS, Dicke F, Rioux K, Workentine ML, Louie TJ, Hirota SA, Greenway SC. Changes in Composition of the Gut Bacterial Microbiome after Fecal Microbiota Transplantation for Recurrent . Front Cardiovasc Med. 2017 Apr 04;4:17. doi: 10.3389/fcvm.2017.00017. eCollection 2017. PMID: 28421185; PMCID: PMC5378704.
Copy Download .nbib Format: NLM
Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015.

Clinical and experimental hepatology

, Halota W, Flisiak R, Boroń-Kaczmarska A, Juszczyk J, Pawłowska M, Simon K, Tomasiewicz K, Małkowski P.
PMID: 28856255
Clin Exp Hepatol. 2015 Nov;1(3):97-104. doi: 10.5114/ceh.2015.55566. Epub 2015 Nov 16.

No abstract available.

Cite
, Halota W, Flisiak R, et al. Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015. Clin Exp Hepatol. 2015;1(3):97-104doi: 10.5114/ceh.2015.55566.
, Halota, W., Flisiak, R., Boroń-Kaczmarska, A., Juszczyk, J., Pawłowska, M., Simon, K., Tomasiewicz, K., & Małkowski, P. (2015). Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015. Clinical and experimental hepatology, 1(3), 97-104. https://doi.org/10.5114/ceh.2015.55566
, et al. "Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015." Clinical and experimental hepatology vol. 1,3 (2015): 97-104. doi: https://doi.org/10.5114/ceh.2015.55566
, Halota W, Flisiak R, Boroń-Kaczmarska A, Juszczyk J, Pawłowska M, Simon K, Tomasiewicz K, Małkowski P. Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015. Clin Exp Hepatol. 2015 Nov;1(3):97-104. doi: 10.5114/ceh.2015.55566. Epub 2015 Nov 16. PMID: 28856255; PMCID: PMC5497415.
Copy Download .nbib Format: NLM
Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study.

Clinical and experimental hepatology

Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K.
PMID: 28856278
Clin Exp Hepatol. 2016 Dec;2(4):138-143. doi: 10.5114/ceh.2016.63870. Epub 2016 Nov 28.

THE AIM OF THE STUDY: Was to analyze the efficacy achieved with regimens available for chronic hepatitis C (CHC) in Poland between 2013 and 2016.MATERIAL AND METHODS: Data were collected from 29 centers and included 6786 patients with available...

Cite
Flisiak R, Pogorzelska J, Berak H, et al. Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016;2(4):138-143doi: 10.5114/ceh.2016.63870.
Flisiak, R., Pogorzelska, J., Berak, H., Horban, A., Orłowska, I., Simon, K., Tuchendler, E., Madej, G., Piekarska, A., Jabłkowski, M., Deroń, Z., Mazur, W., Kaczmarczyk, M., Janczewska, E., Pisula, A., Smykał, J., Nowak, K., Matukiewicz, M., Halota, W., Wernik, J., Sikorska, K., Mozer-Lisewska, I., Rozpłochowski, B., Garlicki, A., Tomasiewicz, K., Krzowska-Firych, J., Baka-Ćwierz, B., Kryczka, W., Zarębska-Michaluk, D., Olszok, I., Boroń-Kaczmarska, A., Sobala-Szczygieł, B., Szlauer, B., Korcz-Ondrzejek, B., Sieklucki, J., Pleśniak, R., Ruszała, A., Postawa-Kłosińska, B., Citko, J., Lachowicz-Wawrzyniak, A., Musialik, J., Jezierska, E., Dobracki, W., Dobracka, B., Hałubiec, J., Krygier, R., Strokowska, A., Chomczyk, W., & Witczak-Malinowska, K. (2016). Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clinical and experimental hepatology, 2(4), 138-143. https://doi.org/10.5114/ceh.2016.63870
Flisiak, Robert, et al. "Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study." Clinical and experimental hepatology vol. 2,4 (2016): 138-143. doi: https://doi.org/10.5114/ceh.2016.63870
Flisiak R, Pogorzelska J, Berak H, Horban A, Orłowska I, Simon K, Tuchendler E, Madej G, Piekarska A, Jabłkowski M, Deroń Z, Mazur W, Kaczmarczyk M, Janczewska E, Pisula A, Smykał J, Nowak K, Matukiewicz M, Halota W, Wernik J, Sikorska K, Mozer-Lisewska I, Rozpłochowski B, Garlicki A, Tomasiewicz K, Krzowska-Firych J, Baka-Ćwierz B, Kryczka W, Zarębska-Michaluk D, Olszok I, Boroń-Kaczmarska A, Sobala-Szczygieł B, Szlauer B, Korcz-Ondrzejek B, Sieklucki J, Pleśniak R, Ruszała A, Postawa-Kłosińska B, Citko J, Lachowicz-Wawrzyniak A, Musialik J, Jezierska E, Dobracki W, Dobracka B, Hałubiec J, Krygier R, Strokowska A, Chomczyk W, Witczak-Malinowska K. Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study. Clin Exp Hepatol. 2016 Dec;2(4):138-143. doi: 10.5114/ceh.2016.63870. Epub 2016 Nov 28. PMID: 28856278; PMCID: PMC5497429.
Copy Download .nbib Format: NLM
Recent advances in synthetic biosafety.

F1000Research

Simon AJ, Ellington AD.
PMID: 27635235
F1000Res. 2016 Aug 31;5. doi: 10.12688/f1000research.8365.1. eCollection 2016.

Synthetically engineered organisms hold promise for a broad range of medical, environmental, and industrial applications. Organisms can potentially be designed, for example, for the inexpensive and environmentally benign synthesis of pharmaceuticals and industrial chemicals, for the cleanup of environmental...

Cite
Simon AJ, Ellington AD. Recent advances in synthetic biosafety. F1000Res. 2016;5doi: 10.12688/f1000research.8365.1.
Simon, A. J., & Ellington, A. D. (2016). Recent advances in synthetic biosafety. F1000Research, 5. https://doi.org/10.12688/f1000research.8365.1
Simon, Anna J, and Ellington, Andrew D. "Recent advances in synthetic biosafety." F1000Research vol. 5 (2016). doi: https://doi.org/10.12688/f1000research.8365.1
Simon AJ, Ellington AD. Recent advances in synthetic biosafety. F1000Res. 2016 Aug 31;5. doi: 10.12688/f1000research.8365.1. eCollection 2016. PMID: 27635235; PMCID: PMC5007755.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1549 entries